The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C

被引:109
作者
Bachmann, M
Kosan, C
Xing, PX
Montenarh, M
Hoffmann, I
Möröy, T
机构
[1] Univ Klinikum Essen, IFZ, Inst Zellbiol Tumorforsch, D-45122 Essen, Germany
[2] Austin Res Inst, Canc Immunotherapy Lab, Heidelberg, Vic 3084, Australia
[3] Univ Saarland, D-66424 Homburg, Germany
[4] Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany
关键词
Pim-1; kinase; Cdc25C phosphatase; cell cycle; G2/M checkpoint;
D O I
10.1016/j.biocel.2005.10.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The proto-oncogene Pim-1 encodes a serine-threonine kinase which is a downstream effector of cytokine signaling and can enhance cell cycle progression by altering the activity of several cell cycle regulators among them the G1 specific inhibitor p21(Waf), the phosphatase Cdc25A and the kinase C-TAK1. Here, we demonstrate by using biochemical assays that Pim-1 can interact with the phosphatase Cdc25C and is able to directly phosphorylate the N-terminal region of the protein. Cdc25C is functionally related to Cdc25A but acts specifically at the G2/M cell cycle transition point and can be inactivated by C-TAK1-mediated phosphorylation. Immuno-fluorescence experiments showed that Pim-1 and Cdc25C co-localize in the cytoplasm of both epithelial and myeloid cells. We find that phosphorylation by Pim-1 enhances the phosphatase activity of Cdc25C and in transfected cells that are arrested in G2/M by bleomycin, Pim-1 can enhance progression into G1. Therefore, we propose that Pim-1 activates Cdc25C by a direct phosphorylation and can thereby assume the function of a positive cell cycle regulator at the G2/M transition. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:430 / 443
页数:14
相关论文
共 55 条
[1]   Pim-1 kinase promotes inactivation of the pro-apoptotic bad protein by phosphorylating it on the Ser112 gatekeeper site [J].
Aho, TLT ;
Sandholm, J ;
Peltola, KJ ;
Mankonen, HP ;
Lilly, M ;
Koskinen, PJ .
FEBS LETTERS, 2004, 571 (1-3) :43-49
[2]   Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis [J].
Alevizos, I ;
Mahadevappa, M ;
Zhang, X ;
Ohyama, H ;
Kohno, Y ;
Posner, M ;
Gallagher, GT ;
Varvares, M ;
Cohen, D ;
Kim, D ;
Kent, R ;
Donoff, RB ;
Todd, R ;
Yung, CM ;
Warrington, JA ;
Wong, DTW .
ONCOGENE, 2001, 20 (43) :6196-6204
[3]   Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc [J].
Allen, JD ;
Verhoeven, E ;
Domen, J ;
vanderValk, M ;
Berns, A .
ONCOGENE, 1997, 15 (10) :1133-1141
[4]   The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1) -: A novel role for Pim-1 at the G2/M cell cycle checkpoint [J].
Bachmann, M ;
Hennemann, H ;
Xing, PX ;
Hoffmann, I ;
Möröy, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (46) :48319-48328
[5]   Pim-1 associates with protein complexes necessary for mitosis [J].
Bhattacharya, N ;
Wang, ZP ;
Davitt, C ;
McKenzie, IFC ;
Xing, PX ;
Magnuson, NS .
CHROMOSOMA, 2002, 111 (02) :80-95
[6]  
Blomberg I, 1999, MOL CELL BIOL, V19, P6183
[7]   Prolactin regulation of pim-1 expression:: Positive and negative promoter elements [J].
Borg, KE ;
Zhang, MY ;
Hegge, D ;
Stephen, RL ;
Buckley, DJ ;
Magnuson, NS ;
Buckley, AR .
ENDOCRINOLOGY, 1999, 140 (12) :5659-5668
[8]   RAPID INDUCTION OF PIM-1 EXPRESSION BY PROLACTIN AND INTERLEUKIN-2 IN RAT NB2 LYMPHOMA-CELLS [J].
BUCKLEY, AR ;
BUCKLEY, DJ ;
LEFF, MA ;
HOOVER, DS ;
MAGNUSON, NS .
ENDOCRINOLOGY, 1995, 136 (12) :5252-5259
[9]   Pim serine/threonine kinases regulate the stability of Socs-1 protein [J].
Chen, XP ;
Losman, JA ;
Cowan, S ;
Donahue, E ;
Fay, S ;
Vuong, BQ ;
Nawijn, MC ;
Capece, D ;
Cohan, VL ;
Rothman, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2175-2180
[10]  
CUYPERS HT, 1984, CELL, V37, P141